<i>N</i>-3-Methylbutyl-benzisoselenazol-3(2H)-one Exerts Antifungal Activity In Vitro and in a Mouse Model of Vulvovaginal Candidiasis
In the present work, we evaluated the antifungal activities of two novel ebselen analogs, <i>N</i>-allyl-benzisoselenazol-3(2H)-one (<i>N</i>-allyl-bs) and <i>N</i>-3-methylbutylbenzisoselenazol-3(2H)-one (<i>N</i>-3mb-bs). Colorimetric and turbidity a...
Main Authors: | Xiuyi Liang, Agata J. Pacuła-Miszewska, Richa Vartak, Milankumar Prajapati, Haiyan Zheng, Caifeng Zhao, Ganming Mao, Ketankumar Patel, Natalya U. Fedosova, Jacek Ścianowski, Blase Billack |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-03-01
|
Series: | Current Issues in Molecular Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/1467-3045/46/3/157 |
Similar Items
-
Selected <i>N</i>-Terpenyl Organoselenium Compounds Possess Antimycotic Activity In Vitro and in a Mouse Model of Vulvovaginal Candidiasis
by: Xiuyi Liang, et al.
Published: (2023-10-01) -
Recurrent Vulvovaginal Candidiasis: An Immunological Perspective
by: Diletta Rosati, et al.
Published: (2020-01-01) -
Vulvovaginal Candidiasis: A Current Understanding and Burning Questions
by: Hubertine M.E. Willems, et al.
Published: (2020-02-01) -
Sertaconazole in the treatment of vulvovaginal candidiasis
by: Z. N. Efendieva
Published: (2019-10-01) -
Use of fluconazole in women of reproductive age with vulvovaginal candidiasis
by: E. A. Mezhevitinova, et al.
Published: (2018-09-01)